Abstract
Prostate cancer is one of the most common malignancies in American men, second only to non-melanoma skin cancer. In 2009, an estimated 192,280 new cases of prostate cancer were diagnosed in the United States, and about 27,360 men died of this disease [1]. The median age at diagnosis is 68 years, and the risk of developing the disease increases in men with advancing age, in those with an affected first-degree relative, and in African American men. The behavior of prostate cancer can vary from a microscopic, well-differentiated cancer with a slow clinical course to an aggressive, poorly differentiated cancer with the potential to invade and spread. Men with prostate cancer can be broadly staged as having localized disease (confined to the prostate), regional disease (i.e., spread to periprostatic fat, seminal vesicles, or pelvic lymph nodes), or distant disease (which metastasizes most commonly to distant lymph nodes and bone).
Original language | English (US) |
---|---|
Title of host publication | 60 Years of Survival Outcomes at The University of Texas MD Anderson Cancer Center |
Publisher | Springer New York |
Pages | 35-43 |
Number of pages | 9 |
ISBN (Electronic) | 9781461451976 |
ISBN (Print) | 1461451965, 9781461451969 |
DOIs | |
State | Published - Aug 1 2013 |
ASJC Scopus subject areas
- General Medicine